[1]
C. R. Lewis, “Investigating the Mechanistic Target of Rapamycin and Analogous Pathways in Cardiovascular Diseases to Augment Cardiac Functionality ”, Jordan j. pharm. sci., vol. 18, no. 2, pp. 317–331, Jun. 2025.